Kyle Rose
Stock Analyst at Canaccord Genuity
(3.34)
# 1,002
Out of 4,911 analysts
114
Total ratings
53.26%
Success rate
13.71%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $31.48 | -14.23% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $286.58 | +13.06% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $396.66 | +9.67% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $53.29 | +33.23% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $27.16 | +161.41% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.53 | +51.41% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.83 | +446.45% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $10.71 | +105.51% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $86.74 | +72.93% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $13.19 | +1,947.01% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $17.36 | +55.53% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.89 | +693.65% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $13.21 | +13.55% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $183.58 | -33.54% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.52 | +13.64% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.40 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $96.87 | +29.04% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $31.48
Upside: -14.23%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $286.58
Upside: +13.06%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $396.66
Upside: +9.67%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $53.29
Upside: +33.23%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $27.16
Upside: +161.41%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.53
Upside: +51.41%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.83
Upside: +446.45%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $10.71
Upside: +105.51%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $86.74
Upside: +72.93%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $13.19
Upside: +1,947.01%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $17.36
Upside: +55.53%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.89
Upside: +693.65%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $13.21
Upside: +13.55%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $183.58
Upside: -33.54%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.52
Upside: +13.64%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.40
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $96.87
Upside: +29.04%